ADENOCARD
Live / Registered — Registered and renewed (as of 12 Jan 2018)
What this means for you
Registered since 26 Jan 1988. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 26 Jan 2018).
Record
- Serial number
- 73628278
- Registration number
- 1473847
- Mark type
- Word mark
- Filed
- 03 Nov 1986
- Published for opposition
- 03 Nov 1987
- Registered
- 26 Jan 1988
- Next maintenance due
- 26 Jan 2018
- Attorney of record
- Heather A. McDonald
Goods and services
- Class 005 — Pharmaceuticals: PHARMACEUTICAL PREPARATIONS - NAMELY, ADENOSINE FOR THE TREATMENT OF CARDIOVASCULAR DISEASES, FOR PARENTERAL ADMINISTRATION BY QUALIFIED MEDICAL PERSONNEL
Owner
- KING PHARMACEUTICALS RESEARCH AND DEVELOPMENT, LLC, New York, NY, US
- KING PHARMACEUTICALS RESEARCH AND DEVELOPMENT, INC., Cary, NC, US
- MEDCO RESEARCH, INC., LOS ANGELES, CA, US
- MEDCO RESEARCH, INC., LOS ANGELES, CA, US
- MEDCO RESEARCH, INC., LOS ANGELES, CA, US
Prosecution history
- 28 Jan 2026 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 28 Jan 2026 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 28 Jan 2026 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 28 Jan 2026 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 28 Mar 2023 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 28 Mar 2023 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 28 Mar 2023 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 28 Mar 2023 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 28 Mar 2023 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 12 Jan 2018 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 12 Jan 2018 — REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
- 12 Jan 2018 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 11 Jan 2018 — TEAS SECTION 8 & 9 RECEIVED
- 27 Dec 2017 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 26 Jan 2017 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED